EXCLUSIVE LICENSE AGREEMENT by and between TESARO, INC. and MILLENNIUM PHARMACEUTICALS, INC. Dated as of July 27, 2017Exclusive License Agreement • November 7th, 2017 • TESARO, Inc. • Pharmaceutical preparations • New York
This EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into as of July 27, 2017 (the “Effective Date”) by and between TESARO, INC., a Delaware corporation having an address at 1000 Winter Street, Suite 3300, Waltham, Massachusetts 02451, U.S.A. (“TESARO”), and MILLENNIUM PHARMACEUTICALS, INC., a Delaware corporation and wholly-owned subsidiary of Takeda Pharmaceutical Company Limited having an address at 40 Landsdowne Street, Cambridge, MA 02139, U.S.A (“Licensee”). TESARO and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
